Expiratory and Plasma Propofol Concentration in Gastrological Surgery Patients
NCT ID: NCT03817541
Last Updated: 2019-02-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
30 participants
INTERVENTIONAL
2018-11-14
2020-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Dexamethasone and Ondansetron Versus Placebo for Postoperative Nausea and Vomiting
NCT01876290
Laparoscopic Cholecystectomy: General Anesthesia With Opioid Versus General Opioid Free Anesthesia
NCT02953210
Sedation of Morbidly Obese for Balloon Insertion
NCT03747094
Propofol Versus Midazolam in Sedation for Upper and Lower Gastrointestinal Endoscopy.
NCT06358131
Intravenous Versus Intraperitoneal Instillation of Ondansetron for Decreasing Incidence of Nausea and Vomiting After Laparoscopic Gynecological Surgeries.
NCT05317611
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The investigators will test the accuracy and stability of such measurements in comparison With plasma propofol Levels.
The investigators will test during target Control infusion (Marsh model) and assumed stable plasma Levels.
Plasma samples of propofol will be taken for comparison With exhaled propofol.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Bariatric surgery
Patients due for bariatric surgery, BMI \> 30
Edmon (reg), BBraun
exhaled propofol will be compared With plasma propofol values
Cholecystectomy
Normal weight patients due for cholecystectomies
Edmon (reg), BBraun
exhaled propofol will be compared With plasma propofol values
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Edmon (reg), BBraun
exhaled propofol will be compared With plasma propofol values
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Both genders.
* Age 18-60 years, both inclusive.
* BMI ≥ 20 kg/m2, 10 patients with BMI 20-30, and 10 patients with BMI \> 40
* ASA classification I-III
Exclusion Criteria
* Patients which during a preoperative visit are deemed not to tolerate propofol bolus or infusion as administered by Target Controlled Infusion.
* Ongoing neuroleptic medication.
18 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Oslo University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Johan C Ræder
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dept of Anesthesiology, Oslo University Hospital, Ullevaal
Oslo, , Norway
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Expiratory propofol gastro
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.